ClinicalTrials.gg
RecruitingNCT06263907SGBUpdated Feb 17, 2026

Stellate Ganglion Block for Prevention of Post Mastectomy Depression

An interventional study of Stellate gangalion block in Mastectomy, Pain, Acute and Pain, Chronic, sponsored by Mansoura University. Recruiting at 1 site in Egypt. Open to female participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by Mansoura University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
21 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Acute Pain with a site in Egypt — 6 open to participants now, 6 under way, none of them phase 3. Acute Pain · Egypt.

Planned enrollment
4th of 40
140 · median 77
Started
2024
with 2 others
No phase
28 of 40
6 open now
Registered
35th of 40
by date
Lead sponsor
3 of 40
Mansoura University

Among the 40 studies in Acute Pain with a site in Egypt, this one is the 4th largest by planned enrollment, is one of 3 that started in 2024, is one of 28 with no phase, and was the 35th registered.

Acute Pain

1,077 studies on the registry are indexed under Acute Pain; 168 are open to participants now.

Browse Acute Pain studies →

Open to participants now

6 of the 40 studies in Acute Pain with a site in Egypt are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 103 Acute Pain studies recruiting now, 40 (39%) set no upper age limit and 50 (49%) stop at 75 or younger; 21 take children under 18; 24 take healthy volunteers.

This study: 21 Years to 65 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Acute Pain with a site in Egypt, or all of them as a file.
02

Study summary

Complications after mastectomy include chronic pain and depression.

Read the detailed description

A mastectomy is surgery could be associated with complications include chronic pain and depression. In female breast cancer patients, the incidence of postoperative depression was 46.55%. Stellate ganglion block had been used for treating post-traumatic stress disorder (PTSD) and depression symptoms even in its prevention. Also, it used in treatment of chronic pain.

03

Conditions studied

  • Mastectomy
  • Pain, Acute
  • Pain, Chronic
04

Who can participate

Ages eligible
21 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients
  • Age ranging from 18 to 65 years
  • (ASA) no more than II
  • Had unilateral cancer breast
  • Scheduled to do unilateral modified radical mastectomy

Exclusion criteria

Exclusion Criteria:

  • Pregnant female
  • Existing Horner syndrome
  • Had any neuromuscular disease
  • Had allergy to local anesthetics
  • History of use of analgesics
  • Had any deformity or a previous surgery in the neck or ipsilateral arm or breast
  • Had any to the procedure (coagulation disorders, local infection, sepsis)
  • Had any contraindication to the sympathetic blockade (decompensate cardiopulmonary or hemodynamic disorders)
  • History of psychotic disorder including depression, bipolar disorder or personality disorder
  • Patient with Beck Depression Inventory (BDI) score more than 13
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    Stellate gangalion block group (Group S)

    Patients will receive ipsilateral stellate gangalion block (4ml) bupivacaine 0.25 %+( 4ml) normal saline + (8mg) dexamethasone in a total 10 ml

    Procedure: Stellate gangalion block

  • No intervention
    Control group (Group C)

    Patients will not receive stellate gangalion block

Interventions

  • ProcedureStellate gangalion block

    The efficacy of Preoperative ipsilateral stellate gangalion block on the occurrence of postmastectomy depression and pain compared with no block

06

What researchers measure

Primary outcomes

  1. incidence of postmastectomy depression

    Beck Depression Inventory (BDI) score

    Time frame: 6 months postoperatively

Secondary outcomes

  1. incidence of postmastectomy depression

    Beck Depression Inventory (BDI) score

    Time frame: 3 months postoperatively

  2. the need for postoperative antidepressant

    needed or not

    Time frame: during the first 6 months postoperatively

  3. acute postoperative pain at the incision site (breast and the axilla)

    Numerical rating scale (NRS) (0-10)

    Time frame: every 12 hour for the first 48 hour recorded

  4. chronic postmastectomy pain at the incision site

    Numerical rating scale (NRS) (0-10)

    Time frame: at 3 and 6 months postoperatively

  5. incidence of nausea and vomiting

    occurred or not

    Time frame: during first 3 postoperative days

  6. Functional pain in the ipsilateral shoulder

    extended from the shoulder to the elbow or to the hand either associated with swelling, changing in the colour or temperature of that limb or associated with reduction in the range of the movement (elbow extension or arm abduction or fixed flexion deformity

    Time frame: during the first 6 months postoperatively

  7. Any complications related to stellate ganglion injection

    local hematoma, persistent postoperative horner's syndrome or respiratory distress

    Time frame: within 1 day postoperatively

07

Study locations

1 of 1 sites recruiting
  • Maha
    Al Mansurah, Egypt
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Nov 2027, 44 months after the start.

Of 425 non-industry interventional studies with no phase under Acute Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 44 months is above that.

Counting every sponsor, half of 431 studies reached it within 11 months; a quarter within 5 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2024
First posted
Feb 16, 2024
StartActual
Mar 1, 2024
Primary completionEst.
Nov 30, 2027
CompletionEst.
Dec 30, 2028
Last update
Feb 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06263907
Responsible party
maha abou-zeid (Assistant Professor of Anaesthesia and Surgical Intensive Care, Mansoura University) — Principal investigator
First posted
Feb 16, 2024
Start date
Mar 1, 2024
Primary completion
Nov 30, 2027 (estimated)
Completion
Dec 30, 2028 (estimated)
Last update
Feb 17, 2026

Study contacts

Maha Abo-Zeid, MD
Contact
mahazed@mans.edu.eg
01019216192

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion